Technical Analysis for COG - Cambridge Cognition Hold

Grade Last Price % Change Price Change
B 141.5 1.07% 1.50
COG closed up 1.07 percent on Friday, April 16, 2021, on 4.47 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical COG trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
New 52 Week High Strength 0.00%
Parabolic Rise Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Older End-of-Day Signals for COG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 1 day ago
Possible Pocket Pivot 1 day ago
5x Volume Pace 1 day ago
3x Volume Pace 1 day ago
2x Volume Pace 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cambridge Cognition Hold Description

Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company's segments include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. The Pharmaceutical Clinical Trials segment includes products and services for use in regulated pharmaceutical clinical trials. The Academic Research segment includes cognitive test products for researchers working in a non-regulated environment, typically in academia. The Healthcare Technology segment includes medical software for use in healthcare delivery settings. The Company is a provider of validated touchscreen cognitive assessments for clinical trials. The Company's product, CANTAB Mobile is a Class II medical device, used to identify patients exhibiting the early signs of Alzheimer's disease. It also offers Cantab Insight for dementia assessment in secondary care.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Healthcare Software Iron Research Pharmaceutical Clinic Disease Earl Medical Device Insight Clinical Trial Pharmaceutical Industry Eim Healthcare Technology E Assessment Technology Segment Alzheimer's Disease Clinical Pharmacology Dementia

Is COG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 146.0
52 Week Low 20.0
Average Volume 54,522
200-Day Moving Average 60.51
50-Day Moving Average 85.67
20-Day Moving Average 100.75
10-Day Moving Average 117.35
Average True Range 7.83
ADX 44.2
+DI 47.63
-DI 7.36
Chandelier Exit (Long, 3 ATRs ) 122.51
Chandelier Exit (Short, 3 ATRs ) 96.49
Upper Bollinger Band 142.29
Lower Bollinger Band 59.21
Percent B (%b) 0.99
BandWidth 82.47
MACD Line 14.71
MACD Signal Line 10.33
MACD Histogram 4.3775
Fundamentals Value
Market Cap 44.11 Million
Num Shares 31.2 Million
EPS -10.00
Price-to-Earnings (P/E) Ratio -14.15
Price-to-Sales 2.53
Price-to-Book 85.01
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 160.85
Resistance 3 (R3) 160.20 153.10 157.63
Resistance 2 (R2) 153.10 148.17 153.43 156.55
Resistance 1 (R1) 147.30 145.13 143.75 147.95 155.47
Pivot Point 140.20 140.20 138.43 140.53 140.20
Support 1 (S1) 134.40 135.27 130.85 135.05 127.53
Support 2 (S2) 127.30 132.23 127.63 126.45
Support 3 (S3) 121.50 127.30 125.38
Support 4 (S4) 122.15